Breast cancer metastasis: mechanisms and therapeutic implications
Breast cancer is the most common malignancy in women worldwide. Metastasis is the
leading cause of high mortality in most cancers. Although predicting the early stage of breast …
leading cause of high mortality in most cancers. Although predicting the early stage of breast …
Targeting metastatic cancer
K Ganesh, J Massague - Nature medicine, 2021 - nature.com
Despite recent therapeutic advances in cancer treatment, metastasis remains the principal
cause of cancer death. Recent work has uncovered the unique biology of metastasis …
cause of cancer death. Recent work has uncovered the unique biology of metastasis …
ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer☆
Metastatic breast cancer (MBC) is an incurable disease, but survival improvements have
been reported with appropriate therapeutic strategies. 1-8 Systemic therapy is the standard …
been reported with appropriate therapeutic strategies. 1-8 Systemic therapy is the standard …
The lingering mysteries of metastatic recurrence in breast cancer
Despite being the hallmark of cancer that is responsible for the highest number of deaths,
very little is known about the biology of metastasis. Metastatic disease typically manifests …
very little is known about the biology of metastasis. Metastatic disease typically manifests …
Breast cancer treatment
KP Trayes, SEH Cokenakes - American family physician, 2021 - aafp.org
Breast cancer is the leading cause of death from cancer in women worldwide, and the
second most common cause of death from cancer in women in the United States. Risk …
second most common cause of death from cancer in women in the United States. Risk …
[HTML][HTML] Triple‑negative breast cancer therapy: Current and future perspectives
KA Won, C Spruck - International journal of …, 2020 - … .spandidos-publications.com
Triple‑negative breast cancer (TNBC) accounts for 10‑15% of all breast cancer cases.
TNBCs lack estrogen and progesterone receptors and express low levels of HER2, and …
TNBCs lack estrogen and progesterone receptors and express low levels of HER2, and …
[HTML][HTML] Functionalized liposomes for targeted breast cancer drug delivery
Despite the exceptional progress in breast cancer pathogenesis, prognosis, diagnosis, and
treatment strategies, it remains a prominent cause of female mortality worldwide …
treatment strategies, it remains a prominent cause of female mortality worldwide …
Impact of the COVID-19 pandemic on breast cancer mortality in the US: estimates from collaborative simulation modeling
Background The coronavirus disease 2019 (COVID-19) pandemic has disrupted breast
cancer control through short-term declines in screening and delays in diagnosis and …
cancer control through short-term declines in screening and delays in diagnosis and …
The exciting new field of HER2-low breast cancer treatment
D Eiger, E Agostinetto, R Saúde-Conde… - Cancers, 2021 - mdpi.com
Simple Summary Breast cancer can express, at varied levels, a protein named HER2,
commonly responsible for making it grow and send distant metastases. In the past, patients …
commonly responsible for making it grow and send distant metastases. In the past, patients …
Breast cancer statistics, 2019
CE DeSantis, J Ma, MM Gaudet… - CA: a cancer journal …, 2019 - Wiley Online Library
This article is the American Cancer Society's biennial update on female breast cancer
statistics in the United States, including data on incidence, mortality, survival, and screening …
statistics in the United States, including data on incidence, mortality, survival, and screening …